Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Microfluidics enables production of shape-controllable microgels

By R&D Editors | February 10, 2015

undefined

click to enlarge

The schematic on top depicts a microfluidic device to create biocompatible particles called shape-controllable microgels that could be custom designed for specific roles such as drug delivery vehicles, tissue engineering building blocks and biomedical research. Below are images of Janus particles, potentially useful for a host of medical and research applications. Image: Purdue Univ./Yuandu Hu and Arezoo Ardekani
 
  

A new, relatively simple process makes it possible to create biocompatible particles called shape-controllable microgels that could be custom designed for specific roles such as drug delivery vehicles, tissue engineering building blocks and biomedical research.

The particles are made of two distinctly different materials: polymers called polyNIPAAm and sodium alginate, used in drug delivery. The two are combined to manufacture so-called Janus particles—named for the Roman god with two distinctly different faces. Like the Roman deity, the particles have two distinctly different sections, a design trait that makes them potentially useful for a host of medical and research applications, said Arezoo Ardekani, an assistant professor of mechanical engineering at Purdue Univ.

A mixture of sodium alginate and polyNIPAAm is formed into uniform droplets using microfluidics, a technology for controlling minute microquantities of fluids with tiny tubes and channels. The droplets are injected into a “collecting solution” containing glycerol and barium acetate. Barium ions diffuse into the resulting droplets, causing them to “crosslink,” or reinforce with chemical bonds, and jellify into squishy mushroom-shaped microgel particles. The particles can be induced to deform into different shapes by varying the concentration of glycerol in the collecting solution; microgels also can “phase separate,” producing Janus particles.

“The novelty of this work is that it is very simple to generate different shapes just by changing the concentration of glycerol,” Ardekani said.

Findings are detailed in a research paper published in Langmuir. The paper was authored by Ardekani, her postdoctoral research associate Yuandu Hu, graduate student Shibo Wang and Harvard Univ. postdoctoral research associate Alireza Abbaspourrad.

The researchers found that varying the concentration of glycerol in the collecting solution alters the shape, surface roughness and physical characteristics of the particles, including color and optical properties, making them potentially useful for technologies such as optical switches.

Having the ability to control the shapes of particles could enable researchers to create a variety of drug-delivery vehicles, while Janus particles hold promise for a number of potential applications. For example, one part might be hydrophobic and the other hydrophilic, allowing them to be positioned and manipulated for tissue engineering or co-delivery of hydrophobic and hydrophilic drugs. Magnetic nanoparticles might be embedded into Janus particles during the fabrication process, making it possible to control them with magnetic fields as delivery vehicles and also for magnetically controlled optical switches. Cells also might be reversibly encapsulated into the microgels for tissue engineering purposes—the cells can be cultured within microgels and easily manipulated into different tissue structures, after which it is possible to dissolve the gels and release the cells; these gels also might be designed to respond to external stimuli such as temperature or pH.

Source: Purdue Univ.

Related Articles Read More >

Female doctor using medical AI assistant on laptop computer in clinic office. modern medicine
Google is teaching healthcare professionals to incorporate AI into the everyday practice of medicine
Carnyx targets 2027 IND filing for oral sleep candidate CNYX-005
OpenAI unveils BioBasicsBench, a benchmark to gauge how well AI agents read raw experimental data across 100 routine wet-lab tasks.
Kosmos world model diagram: three colored paths of connected nodes trace three discoveries built from data-analysis agent steps, literature-review agent steps and established findings.
Edison’s Kosmos AI scientist moves into Pfizer R&D; Edison details the math behind its $99 million-per-program estimate
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2026 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE